Navigation Links
Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results
Date:11/3/2010

HOUSTON, Nov. 3, 2010 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the second quarter ended October 29, 2010 of its fiscal year ending April 29, 2011 on Monday, November 22, 2010 at 8:00 AM ET.  The company will conduct a conference call to discuss those results on the same day at 9:00 AM ET .

Fiscal Year 2011 Second Quarter Results Conference Call InstructionsTo listen to the conference call live by telephone dial 877-313-8035 (if dialing from within the U.S.) or 706-679-4838 (if dialing from outside the U.S.).  The conference ID is 22043442.  Presentation slides will be available on-line at www.cyberonics.com no later than 8:00 AM ET on Monday, November 22, 2010.  A replay of the conference call will be available approximately two hours after the completion of the conference call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing from outside the U.S.).  The replay conference ID access code is 22043442.  The replay will be available for one week on the above number and subsequently on the company's website for a period of six months.

About Cyberonics, Inc. and VNS Therapy®Cyberonics, Inc. (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation.  The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and VNS Therapy is available at www.cyberonics.com.CONTACT INFORMATION:Greg Browne, CFOCyberonics, Inc.100 Cyberonics Blvd.Houston, TX 77058Main:  (281) 228-7262Fax:  (281) 218-9332ir@cyberonics.com
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cyberonics Reports Inducement Equity Awards Under NASDAQ Listing Rule 5635(c)(4)
2. Cyberonics to Participate in Upcoming September Investor Conferences
3. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
4. Cyberonics Announces Epilepsy Technology Agreements
5. Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference
6. Cyberonics Provides Update on Tax Position
7. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results
8. Cyberonics Provides Update on Depression Post-Approval Study
9. Benchmark Electronics Announces Thailand Facility Class III Medical Device Manufacturing Capabilities
10. PharmAthene Announces Closing of $15 Million Public Offering
11. Cypin Production Announces Launch of U.S./China BioPharma Conference:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated stainless ... FDA requirements, which stipulates new criteria regarding medical device manufacture and ... ID jewelry such as Medical ID Bracelets, can rest assured that ... the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process with ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
Breaking Medicine Technology:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
Breaking Medicine News(10 mins):